GeneDx presents at J.P. Morgan Healthcare Conference; full presentation details not available in filing

GeneDx Holdings Corp.

Investor presentation furnished as Exhibit 99.1 for the 41st Annual J.P. Morgan Healthcare Conference on January 12, 2023.
Tagline: 'One Test: Miss Less. Discover More.' CEO Katherine Stueland presented.
No specific financial guidance or operational metrics were extractable from the truncated filing exhibit.
The presentation may contain material information, but the full content was not provided in the current filing.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.